Navigation Links
HDMA's Gray: Passage Of National Pharmaceutical Traceability Legislation A Critical Accomplishment For Healthcare Industry And Patients
Date:11/18/2013

ARLINGTON, Va., Nov. 18, 2013 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on the passage of national pharmaceutical traceability legislation (Drug Quality and Security Act/H.R. 3204) by the U.S. Senate.

"Today the Senate voted to establish a national traceability framework for prescription medicines. The federal preemption of state laws to further strengthen the U.S. pharmaceutical supply chain represents one of the most significant legislative accomplishments for our industry and, is especially important for the healthcare providers and pharmacies — and their patients — who count on the safe and efficient distribution of prescription medicines. Thanks to the commitment and hard work of the U.S. Congress, the 50-state patchwork of regulations will be replaced with one federal solution, ensuring the seamless movement and traceability of pharmaceuticals throughout the supply chain. This victory is the culmination of nearly a decade's worth of work by HDMA and all those who championed this issue. We applaud Congress for passing legislation to establish one national solution for a safer, more secure pharmaceutical supply chain, and urge President Obama to swiftly sign the bill into law."

Continue the conversation about federal pharmaceutical traceability on Twitter through the hashtag #1RxSolution.             

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that 15 million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system. For more information, visit www.HealthcareDistribution.org.


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
2. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
3. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
4. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
5. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
6. Boston Scientific Commends Congress on Passage of Bill Reauthorizing Medical Device User Fees
7. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in the U.S. Senate
8. Medical Device Manufacturing Coalition Applauds Passage of Medical Device Tax Repeal Amendment
9. CHPA Applauds Governor Mike Pence and the Passage of SB 496
10. HDMA Statement On House Passage Of Federal Traceability Legislation
11. LaserLock Technologies Applauds the U.S. House Passage of the Drug Quality and Security Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Bill Howe Plumbing, Heating ... the American Heart Association; “Howe” Healthy is Your Heart Drawing Contest The ... active. Each year, Bill Howe Plumbing, Heating & Air receives over 600 entries. The ...
(Date:1/19/2017)... Marriottsville, MD (PRWEB) , ... January 19, 2017 , ... ... launched six new clients into the US market. , Over the past 20 years ... the past 4 weeks SFI has launched six new clients into the US market. ...
(Date:1/19/2017)... Georgia (PRWEB) , ... January 19, 2017 , ... ... Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons ... advancements in breast surgery. Covering topics from cosmetic breast augmentation to ...
(Date:1/18/2017)... ... 2017 , ... A recent video posting of a new fidget product gathered ... fidgeting to relieve stress and anxiety. No one was more surprised than Think ... just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive ... go untreated. , Certain Dri created this infographic to explain the seven types ...
Breaking Medicine News(10 mins):